January 30th, 2024 - Toronto, Ontario - NuGen Medical Devices Inc. (TSXV: NGMD) (the “Company” or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of January 30th, 2024, Sol-Millennium Medical Inc.’s (“Sol-M”) global sales & marketing team has now completed their in-depth clinical training of NuGen’s needle-free InsuJet™ medical device for sales and marketing throughout Europe. Louise Cresswell, NuGen’s VP of Sales & Marketing for the UK and clinical expert, provided specialized training to a ...
[ more ]
